
    
      Multicentre, double-blind, randomised, parallel groups, placebo-controlled study to be
      conducted in specialized centres in Europe to investigate the safety, tolerability,
      pharmacokinetics and pharmacodynamics of two different doses of Rec 0/0438 in comparison with
      placebo, in subjects with neurogenic detrusor overactivity due to spinal cord injury.
    
  